Previous close | 0.3634 |
Open | 0.3744 |
Bid | 0.3600 x 1300 |
Ask | 0.3800 x 3100 |
Day's range | 0.3600 - 0.3845 |
52-week range | 0.2560 - 2.5800 |
Volume | |
Avg. volume | 1,393,227 |
Market cap | 55.304M |
Beta (5Y monthly) | 1.33 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2690 |
Earnings date | 31 May 2022 - 07 Jun 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.33 |
Renew joins 33 other NewAge products certified by the world’s leading independent scientific laboratory in the field of analytical testing for banned substances in nutritional supplementsSALT LAKE CITY, May 18, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), a direct selling company with a primary focus on healthy products, today announced that Nutrifii™ Renew has joined 33 other NewAge products in being certified by the globally renowned Cologne List® (Kölner Liste), an independent scient
SALT LAKE CITY, May 17, 2022 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV) (the “Company” or “NewAge”), announced that it received an additional delinquency notice from the Nasdaq Stock Market on May 12, 2022 notifying the Company that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) due to the Company’s failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Ru
SALT LAKE CITY, April 04, 2022 (GLOBE NEWSWIRE) -- As previously announced, on March 16, 2022, NewAge, Inc. (Nasdaq: NBEV) (the “Company” or “NewAge”), filed a Notification of Late Filing on Form 12b-25 indicating that the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Annual Report”) would be delayed. In addition, on March 31, 2022, the Company filed a Form 8-K indicating that the Company would be unable to file its Annual Report within the 15-day ext